HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ruoxin Wei Selected Research

Retinaldehyde (Retinal)

9/2015Expression of Toll-like receptors in human retinal and choroidal vascular endothelial cells.
6/2010A glycine site-specific NMDA receptor antagonist protects retina ganglion cells from ischemic injury by modulating apoptotic cascades.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ruoxin Wei Research Topics

Disease

1Glaucoma
05/2020
1Anterior Uveitis
05/2020
1Vascular Diseases (Vascular Disease)
09/2015
1Ocular Hypertension (Glaucoma, Suspect)
03/2011
1Reperfusion Injury
06/2010
1Ganglion Cysts (Ganglion)
06/2010

Drug/Important Bio-Agent (IBA)

2Retinaldehyde (Retinal)IBA
09/2015 - 06/2010
1SuspensionsIBA
05/2020
1SteroidsIBA
05/2020
1rimexolone (Vexol)FDA Link
05/2020
1Prednisolone (Predate)FDA LinkGeneric
05/2020
1tetrandrineIBA
03/2011
1DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
06/2010
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
06/2010
1Glycine (Aminoacetic Acid)FDA LinkGeneric
06/2010

Therapy/Procedure

1Semiconductor Lasers
03/2011